Dark

REGN
Regeneron Pharmaceuticals Inc
stock NASDAQ

At Close

Jun 11, 2026 3:59:59 PM EDT

611.03USD+1.560%(+9.38)925,669

584.82Bid 642.60Ask 57.78Spread

Pre-market

Jun 10, 2026 9:16:30 AM EDT

617.97USD+2.713%(+16.32)0

After-hours

Jun 11, 2026 4:19:30 PM EDT

605.00USD-0.988%(-6.03)159,013

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

64.03B

CEO

Leonard Schleifer

Headquarters

Tarrytown, New York, USA

Industry

Biotechnology

Next Earnings

Jul 30, 2026 (49d)

Last Dividend

May 20, 20260.940

AMGN BIIB ALNY NVS JNJ SNY OPHT XLV

REGN Stats

Avg. Vol. 10 Day

1,178,341

Avg. Vol. 30 Day

1,125,208

Employees

6,200

Market Cap

64,032,535,575

Shares Out.

104,839,032

On/Off Exchange

54%/46%

6 Month Beta

0.63

1 Year Beta

0.49

2 Year Beta

0.63

3 Year Beta

0.61

52 Week Low

503.25

52 Week High

821.11

SMA50

698.82

SMA200

696.14

1 Week

-2.86%

1 Month

-14.31%

3 Month

-21.16%

6 Month

-18.22%

1 Year

+17.77%

2 Year

-39.56%

5 Year

+16.22%

Profile

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.

REGN Stock Summary

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) stock price today is $611.03, and today's volume is 925,669. REGN is up 1.560% today. The 30 day average volume is 1,125,208. REGN market cap is 64.03B with 104,839,032 shares outstanding.